Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Windtree Therapeutics	Brickell Biotech	Organovo	Genetic Technologies	BioCardia
Symbol	NASDAQ:WINT	NASDAQ:BBI	NASDAQ:ONVO	NASDAQ:GENE	NASDAQ:BCDA
Price Information
Current Price	$2.10	$0.97	$7.56	$3.98	$3.47
52 Week Range	Buy	Buy	N/A	N/A	Buy
MarketRank™
Overall Score	2.3	1.6	0.7	0.4	1.2
Analysis Score	3.5	3.5	0.0	0.0	3.3
Community Score	5.0	1.4	2.5	1.9	1.2
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	1.7	0.8	0.0	0.8
Earnings & Valuation Score	1.3	1.3	0.0	0.0	0.6
Analyst Ratings
Consensus Recommendation	Buy	Buy	N/A	N/A	Buy
Consensus Price Target	$12.25	$5.50	N/A	N/A	$9.25
% Upside from Price Target	483.33% upside	469.00% upside	N/A	N/A	166.57% upside
Trade Information
Market Cap	$55.14 million	$64.70 million	$53.81 million	$59.81 million	$58.27 million
Beta	0.25	0.34	0.85	2.65	1.98
Average Volume	348,264	3,193,345	309,487	1,748,227	257,635
Sales & Book Value
Annual Revenue	$200,000.00	$7.92 million	$2.20 million	$10,000.00	$710,000.00
Price / Sales	275.70	8.17	24.46	5,981.14	82.07
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$5.48 per share	$0.97 per share	$4.08 per share	$0.65 per share	$0.35 per share
Price / Book	0.38	1.00	1.85	6.12	9.91
Profitability
Net Income	$-27,480,000.00	$-23,880,000.00	$-18,710,000.00	$-4,090,000.00	$-14,710,000.00
EPS	($2.52)	($5.11)	N/A	N/A	($2.61)
Trailing P/E Ratio	N/A	N/A	0.00	0.00	N/A
Forward P/E Ratio	N/A	N/A	∞	∞	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-990.67%	N/A	N/A	-5,103.95%
Return on Equity (ROE)	-43.46%	-187.45%	-71.01%	N/A	-496.87%
Return on Assets (ROA)	-26.55%	-114.85%	-67.22%	N/A	-178.90%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.18%	N/A	N/A	0.02%	0.05%
Current Ratio	2.75%	3.50%	29.61%	10.88%	1.99%
Quick Ratio	2.75%	3.50%	29.61%	10.81%	1.99%
Ownership Information
Institutional Ownership Percentage	1.59%	5.93%	48.67%	1.39%	9.01%
Insider Ownership Percentage	14.91%	10.30%	5.10%	N/A	40.90%
Miscellaneous
Employees	31	13	7	N/A	24
Shares Outstanding	26.26 million	66.93 million	7.12 million	15.03 million	16.79 million
Next Earnings Date	5/13/2021 (Estimated)	5/13/2021 (Confirmed)	5/10/2021 (Estimated)	N/A	5/21/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Optionable	Optionable	Not Optionable

Source	Headline
	BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates - GlobeNewswire globenewswire.com - April 26 at 2:08 PM
	BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates - Yahoo Finance finance.yahoo.com - April 26 at 8:23 AM
	BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates finance.yahoo.com - April 26 at 8:23 AM
	BioCardia (NASDAQ:BCDA) Given Neutral Rating at Dawson James americanbankingnews.com - April 22 at 9:36 AM
	Semi-Automated Biochemical Urine Analyzer Market 2021 Overview, Opportunities, In-Depth Analysis by 2027: Athersys, Inc., Bayer AG, BioCardia, Inc., FibroGen, Inc., Hemostemix Ltd, HUYA Bioscience International, LLC - Los Hijos de la Malinche loshijosdelamalinche.com - April 19 at 7:11 AM
	BioCardia (NASDAQ:BCDA) Downgraded by Dawson James americanbankingnews.com - April 17 at 2:58 PM
	BioCardia, Inc. (NASDAQ:BCDA) Sees Significant Increase in Short Interest americanbankingnews.com - April 17 at 1:00 AM
	Steerable Introducers Market Size by Recent Developments 2021 Business Trends Evaluation, Leading Players Updates – Merit Medical, Boston Scientific, Abbott, BioCardia, Integer - Los Hijos de la Malinche loshijosdelamalinche.com - April 15 at 8:42 AM
	Should You Take Comfort From Insider Transactions At BioCardia, Inc. (NASDAQ:BCDA)? - Nasdaq nasdaq.com - April 8 at 2:13 PM
	SRNE Stock - SRNE Stock - BUZZ-US STOCKS ON THE MOVE-Infinity Pharmaceuticals, BioCardia, Caesars Entertainment, TransMedics Group \| Fintech Zoom - Fintech Zoom fintechzoom.com - April 3 at 9:47 PM
	Sorrento Therapeutics, Inc. (SRNE) Stock Price, News - Fintech Zoom fintechzoom.com - April 3 at 9:47 PM
	SRNE Stock - BUZZ-US STOCKS ON THE MOVE-Infinity Pharmaceuticals, BioCardia, Caesars Entertainment, TransMedics Group - Fintech Zoom fintechzoom.com - April 3 at 4:46 PM
	Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares? - Yahoo Finance finance.yahoo.com - April 1 at 10:13 AM
	Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares? finance.yahoo.com - April 1 at 7:19 AM
	BioCardia Reports 2020 Financial Results and Recent Business Highlights - GlobeNewswire globenewswire.com - April 1 at 5:13 AM
	Tencent To Buy Back $1B In Stock; Shares Gain Pre-Market - Nasdaq nasdaq.com - March 31 at 8:39 AM
	4 Stocks Poised to Gain From Uptick in Campus Networking Spend - Nasdaq nasdaq.com - March 30 at 10:38 PM
	Deutsche (DB) Might File Lawsuit Against Two Ex-Madoff Funds - Nasdaq nasdaq.com - March 30 at 12:50 PM
	BlackBerry (BB) QNX Software Boosts Scania's Heavy Vehicles - Nasdaq nasdaq.com - March 30 at 12:37 PM
	Viasat (VSAT) Arm Sets Up Facility in UK to Boost Cybersecurity - Nasdaq nasdaq.com - March 30 at 12:37 PM
	Form 10-K BioCardia, Inc. For: Dec 31 - StreetInsider.com streetinsider.com - March 30 at 12:37 PM
	BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance finance.yahoo.com - March 30 at 12:37 PM
	BioCardia Reports 2020 Financial Results and Recent Business Highlights - Yahoo Finance finance.yahoo.com - March 30 at 12:37 PM
	BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates finance.yahoo.com - March 30 at 12:36 PM
	BioCardia Reports 2020 Financial Results and Recent Business Highlights finance.yahoo.com - March 30 at 9:16 AM

Date	Company	Brokerage	Action
6/26/2020	Windtree Therapeutics	LADENBURG THALM/SH SH	Initiated Coverage
4/26/2021	Brickell Biotech	Oppenheimer	Reiterated Rating
8/28/2020	Brickell Biotech	Lake Street Capital	Initiated Coverage
8/8/2019	Organovo	HC Wainwright	Downgrade
7/27/2018	Organovo	Jefferies Financial Group	Reiterated Rating
4/22/2021	BioCardia	Dawson James	Reiterated Rating
9/21/2020	BioCardia	Alliance Global Partners	Initiated Coverage
8/14/2020	BioCardia	Maxim Group	Initiated Coverage
11/26/2019	BioCardia	Brookline Capital Management	Reiterated Rating

(Data available from 5/6/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources